Recently, Sec22b, a SNARE family member modulating the protein trafficking from ER to the endocytic and phagocytic pathways, has been shown to play a crucial role in antigen cross-presentation for effective anti-tumor immunity in vivo (46). Here, SEC22B is linked to neoplasm.